FOENIX-101: a phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements
Goyal, L Bahleda, R Furuse, J Moehler, MH Oh, DY Chang, HM Kelley, RK Javle, MM Borad, MJ
Goyal, L
Bahleda, R
Furuse, J
Moehler, MH
Oh, DY
Chang, HM
Kelley, RK
Javle, MM
Borad, MJ
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Goyal L, Bahleda R, Furuse J, Valle JW, Moehler MH, Oh D-Y, et al. FOENIX-101: a phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements. J Clin Oncol. 2019;37(4_suppl):TPS468-TPS.